{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T14:51:59Z","timestamp":1793717519342,"version":"4.6.1"},"reference-count":23,"publisher":"Cambridge University Press (CUP)","license":[{"start":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T00:00:00Z","timestamp":1621296000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Laryngol. Otol."],"abstract":"<jats:title>Abstract<\/jats:title>\n\t  <jats:sec id=\"S0022215121001456_sec_a1\">\n\t    <jats:title>Background<\/jats:title>\n\t    <jats:p>Acute epistaxis can be a life-threatening airway emergency, requiring in-patient admission. The coronavirus disease 2019 pandemic placed significant strain on hospital resources, and management has shifted towards an out-patient-centred approach.<\/jats:p>\n\t  <\/jats:sec>\n\t  <jats:sec id=\"S0022215121001456_sec_a2\" sec-type=\"methods\">\n\t    <jats:title>Methods<\/jats:title>\n\t    <jats:p>A five-month single-centre retrospective study was undertaken of all epistaxis patients managed by the ENT department. A pre-coronavirus disease 2019 pandemic group was managed with pre-existing guidelines, compared to new guidelines for the coronavirus disease 2019 pandemic group. A telephone survey was performed on out-patients with non-dissolvable packs to assess patient comfort and satisfaction.<\/jats:p>\n\t  <\/jats:sec>\n\t  <jats:sec id=\"S0022215121001456_sec_a3\" sec-type=\"results\">\n\t    <jats:title>Results<\/jats:title>\n\t    <jats:p>A total of 142 patients were seen. The coronavirus disease 2019 pandemic group had significantly more patients aged over 65 years (<jats:italic>p<\/jats:italic> = 0.004), an increased use of absorbable dressings and local haemostatic agents (Nasopore and Surgiflo), and fewer admissions (all <jats:italic>p<\/jats:italic> &lt; 0.0005). Rates of re-presentation and morbidity, and length of hospital stay were similar. The telephone survey revealed out-patient management to be efficacious and feasible.<\/jats:p>\n\t  <\/jats:sec>\n\t  <jats:sec id=\"S0022215121001456_sec_a4\" sec-type=\"conclusions\">\n\t    <jats:title>Conclusion<\/jats:title>\n\t    <jats:p>The coronavirus disease 2019 pandemic has shifted epistaxis management towards local haemostatic agents and out-patient management; this approach is as safe and effective as previously well-established regimens.<\/jats:p>\n\t  <\/jats:sec>","DOI":"10.1017\/s0022215121001456","type":"journal-article","created":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T09:36:33Z","timestamp":1621330593000},"page":"1-5","source":"Crossref","is-referenced-by-count":4,"title":["Coronavirus disease 2019: changing the future of emergency epistaxis management"],"prefix":"10.1017","author":[{"given":"Y","family":"Devabalan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Cereceda-Monteoliva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Lorenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J C","family":"Magill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Unadkat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Rennie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2021,5,18]]},"reference":[{"key":"S0022215121001456_ref8","doi-asserted-by":"publisher","DOI":"10.1017\/S0022215117002055"},{"key":"S0022215121001456_ref16","doi-asserted-by":"publisher","DOI":"10.1111\/coa.13717"},{"key":"S0022215121001456_ref4","doi-asserted-by":"publisher","DOI":"10.1177\/0194599817705619"},{"key":"S0022215121001456_ref1","doi-asserted-by":"publisher","DOI":"10.1017\/S002221511700202X"},{"key":"S0022215121001456_ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s40463-020-00425-6"},{"key":"S0022215121001456_ref5","unstructured":"5 ENTUK. ENTUK Guidelines for changes in ENT during COVID-19 Pandemic. In: https:\/\/www.entuk.org\/entuk-guidelines-changes-ent-during-covid-19-pandemic [2 March 2021]"},{"key":"S0022215121001456_ref14","unstructured":"14 Nuffield Trust. Where are the patients? The factors affecting the use of emergency care during COVID-19. In: https:\/\/www.nuffieldtrust.org.uk\/news-item\/where-are-the-patients-the-factors-affecting-the-use-of-emergency-care-during-covid-19 [5 March 2021]"},{"key":"S0022215121001456_ref23","doi-asserted-by":"publisher","DOI":"10.4193\/Rhin13.020"},{"key":"S0022215121001456_ref10","unstructured":"10 Gov.uk. Major new measures to protect people at highest risk from coronavirus 2020. In: https:\/\/www.gov.uk\/government\/news\/major-new-measures-to-protect-people-at-highest-risk-from-coronavirus [4 March 2021]"},{"key":"S0022215121001456_ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2004.12.014"},{"key":"S0022215121001456_ref12","doi-asserted-by":"publisher","DOI":"10.2196\/23775"},{"key":"S0022215121001456_ref17","doi-asserted-by":"publisher","DOI":"10.1097\/01.MLG.0000160528.50017.3C"},{"key":"S0022215121001456_ref18","doi-asserted-by":"publisher","DOI":"10.1002\/lary.27081"},{"key":"S0022215121001456_ref2","doi-asserted-by":"publisher","DOI":"10.1017\/S0022215117002018"},{"key":"S0022215121001456_ref19","doi-asserted-by":"publisher","DOI":"10.1186\/s40463-017-0248-5"},{"key":"S0022215121001456_ref13","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6923e1"},{"key":"S0022215121001456_ref20","doi-asserted-by":"publisher","DOI":"10.1017\/S0022215106003148"},{"key":"S0022215121001456_ref21","doi-asserted-by":"publisher","DOI":"10.1111\/coa.13716"},{"key":"S0022215121001456_ref22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2273.2005.01019.x"},{"key":"S0022215121001456_ref3","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.2004.025007"},{"key":"S0022215121001456_ref6","unstructured":"6 ENTUK. Guidance for ENT during the COVID-19 pandemic. In: https:\/\/www.entuk.org\/guidance-ent-during-covid-19-pandemic [2 March 2021]"},{"key":"S0022215121001456_ref11","unstructured":"11 ENTUK. COVID-19 epistaxis management. In: https:\/\/www.entuk.org\/sites\/default\/files\/files\/COVID%2019%20Epistaxis%20Management.pdf [14 May 2021]"},{"key":"S0022215121001456_ref15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0093959"}],"container-title":["The Journal of Laryngology &amp; Otology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0022215121001456","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T06:41:51Z","timestamp":1624603311000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0022215121001456\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,18]]},"references-count":23,"alternative-id":["S0022215121001456"],"URL":"https:\/\/doi.org\/10.1017\/s0022215121001456","relation":{},"ISSN":["0022-2151","1748-5460"],"issn-type":[{"value":"0022-2151","type":"print"},{"value":"1748-5460","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,18]]}}}